---
title: "Plasma p‑tau217, p‑tau181, GFAP and NfL Predict Diagnosis and Long‑Term Progression in a 3,645‑Pat"
id: "medrxiv-20-plasma-biomarkers-and-incident-clinical-stage-progression-in-the-specialized"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-20-plasma-biomarkers-and-incident-clinical-stage-progression-in-the-specialized"
content_type: "clinical_feed_article"
specialty: "Neurology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.10.19.26365317v1?rss=1"
published_at: "2026-10-21T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Plasma p‑tau217, p‑tau181, GFAP and NfL Predict Diagnosis and Long‑Term Progression in a 3,645‑Pat
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-20-plasma-biomarkers-and-incident-clinical-stage-progression-in-the-specialized
- **Specialty:** [Neurology](https://medichelpline.com/clinical-feed/neurology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.10.19.26365317v1?rss=1)
- **Published At:** 2026-10-21T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Investigators analyzed plasma **p‑tau217**, **p‑tau181**, **GFAP**, and **NfL** in a large memory‑clinic cohort of 3,645 participants with baseline clinical evaluation and annual follow‑up extending up to three decades. - The study team reported that **p‑tau217**, **p‑tau181**, and **GFAP** were associated with **amyloid‑beta (Aβ)** pathology on available reference measures; all four markers were elevated in clinical **Alzheimer’s disease (AD)** and in all‑cause dementia. - Diagnostic performance: **p‑tau217** outperformed the other plasma markers for identifying **Aβ** pathology and clinical **AD**, while **p‑tau217**, **GFAP**, and **NfL** performed similarly when discriminating all‑cause dementia. - Prognostic performance: **p‑tau217** showed the strongest association with longitudinal cognitive decline and best predicted progression status at 5‑ and 10‑year intervals; **GFAP** and **NfL** followed in predictive strength. - Models that included plasma biomarkers provided added prognostic value beyond demographic and genetic covariates, according to the authors. - The cohort’s long follow‑up enabled interval analyses (5‑ and 10‑year progression), but the authors noted the need for population‑specific approaches and other limitations described in the preprint. - The preprint has not been peer reviewed; authors disclosed patent interests related to biofluid biomarker methods and reagents.
## Clinical Analysis & Structured Key Points
Plasma biomarkers and incident clinical stage progression in the specialized memory clinic: a longitudinal study | medRxiv Skip to main content Plasma biomarkers and incident clinical stage progression in the specialized memory clinic: a longitudinal study View ORCID Profile Xuemei zeng , View ORCID Profile Nicholas Heaton , View ORCID Profile Rebecca A. Deek , View ORCID Profile Michel N. Nafash , View ORCID Profile Marissa F. Farinas , Lamia T. Choity , View ORCID Profile Wasiu G. Balogun , View ORCID Profile Ruyu Shi , Margaret A. Bedison , Brian J. Lopresti , View ORCID Profile Cristy Matan , View ORCID Profile Neelesh K. Nadkarni , View ORCID Profile Alexandra Gogola , View ORCID Profile Elizabeth C. Shaaban , View ORCID Profile Howard J. Aizenstein , View ORCID Profile Dana L. Tudorascu , View ORCID Profile Tharick A. Pascoal , Victor L. Villemagne , View ORCID Profile Sarah B. Berman , Milos D. Ikonomovic , View ORCID Profile Robert A. Sweet , Julia K. Kofler , Beth E. Snitz , View ORCID Profile Ilyas M. Kamboh , View ORCID Profile Ann D. Cohen , Oscar L. Lopez , View ORCID Profile Thomas K Karikari doi: https://doi.org/10.64898/2026.10.19.26365317 Xuemei zeng University of Pittsburgh Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Xuemei zeng Nicholas Heaton University of Pittsburgh Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Nicholas Heaton Rebecca A. Deek University of Pittsburgh Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Rebecca A. Deek Michel N. Nafash University of Pittsburgh Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Michel N. Nafash Marissa F. Farinas University of Pittsburgh Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Marissa F. Farinas Lamia T. Choity University of Pittsburgh Find this author on Google Scholar Find this author on PubMed Search for this author on this site Wasiu G. Balogun University of Pittsburgh Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Wasiu G. Balogun Ruyu Shi University of Pittsburgh Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Ruyu Shi Margaret A. Bedison University of Pittsburgh Find this author on Google Scholar Find this author on PubMed Search for this author on this site Brian J. Lopresti University of Pittsburgh Find this author on Google Scholar Find this author on PubMed Search for this author on this site Cristy Matan University of Pittsburgh Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Cristy Matan Neelesh K. Nadkarni University of Pittsburgh Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Neelesh K. Nadkarni Alexandra Gogola University of Pittsburgh Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Alexandra Gogola Elizabeth C. Shaaban University of Pittsburgh Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Elizabeth C. Shaaban Howard J. Aizenstein University of Pittsburgh Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Howard J. Aizenstein Dana L. Tudorascu University of Pittsburgh Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Dana L. Tudorascu Tharick A. Pascoal University of Pittsburgh Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Tharick A. Pascoal Victor L. Villemagne University of Pittsburgh Find this author on Google Scholar Find this author on PubMed Search for this author on this site Sarah B. Berman University of Pittsburgh Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Sarah B. Berman Milos D. Ikonomovic University of Pittsburgh Find this author on Google Scholar Find this author on PubMed Search for this author on this site Robert A. Sweet University of Pittsburgh Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Robert A. Sweet Julia K. Kofler University of Pittsburgh Find this author on Google Scholar Find this author on PubMed Search for this author on this site Beth E. Snitz University of Pittsburgh Find this author on Google Scholar Find this author on PubMed Search for this author on this site Ilyas M. Kamboh University of Pittsburgh Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Ilyas M. Kamboh Ann D. Cohen University of Pittsburgh Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Ann D. Cohen Oscar L. Lopez University of Pittsburgh Find this author on Google Scholar Find this author on PubMed Search for this author on this site Thomas K Karikari University of Pittsburgh Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Thomas K Karikari For correspondence: karikaritk{at}upmc.edu Abstract Info/History Metrics Supplementary material Data/Code Preview PDF Abstract INTRODUCTION: The utility of blood‑based Alzheimer's disease (AD) biomarkers in predicting clinical trajectories remains uncertain. METHODS: We assessed the diagnostic and prognostic performance of p-tau181, p-tau217, GFAP, and NfL in a large memory‑clinic cohort (n=3,645) with comprehensive baseline clinical evaluation and annual follow‑up for up to three decades. RESULTS: P-tau217, p-tau181 and GFAP were associated with amyloid-beta (Aβ) pathology, while all biomarkers were elevated in AD and all-cause dementia. P-tau217 significantly outperformed others in detecting Aβ pathology and clinical AD but performed similarly to NfL and GFAP for all-cause dementia. Prognostically, p‑tau217 demonstrated the strongest association with cognitive decline, followed by GFAP and NfL, and best predicted progression status at 5‑ and 10‑year intervals. All biomarkers provided added prognostic value beyond demographic and genetic covariates. DISCUSSION: These findings support plasma biomarkers for disease identification and risk stratification while underscoring the need for population‑specific approaches. Competing Interest Statement XZ and TKK are inventors on patents and provisional patents regarding biofluid biomarker methods, targets and reagents/compositions, that may generate income for the institution and/or self should they be licensed and/or transferred to another organization. TKK has served as an adhoc consultant and/or advisory board member for Quanterix Corporation, SpearBio Inc., Neurogen Biomarking LLC., Alzheon, Siemens Healthineers and Neurogen Biomarking LLC., outside the submitted work. TKK has received royalties from Bioventix for the transfer of specific antibodies and blood biomarker assays to third party organizations. The other authors have nothing to declare. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The Human Research Protection Office/IRB of the University of Pittsburgh gave ethical approval for this work. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability All data produced in the present study are available upon reasonable request to the authors Funder Information Declared National Institute on Aging National Institute on Aging , R01 AG083874 , U24AG082930 , RF1AG077474 , R01 AG083156 , R37 AG023651 , R01 AG025516 , R01 AG073267 , R01 AG075336 , R01 AG072641 , P01 AG025204 , P01 AG14449 , R01AG013672 National Institute of Neurological Disorders and Stroke (NINDS) , U01 NS131740 , U01 NS141777 Aging Mind Foundation , DAF2255207 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license . Back to top Previous Next Posted October 21, 2026. Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Plasma biomarkers and incident clinical stage progression in the specialized memory clinic: a longitudinal study Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Plasma biomarkers and incident clinical stage progression in the specialized memory clinic: a longitudinal study Xuemei zeng , Nicholas Heaton , Rebecca A. Deek , Michel N. Nafash , Marissa F. Farinas , Lamia T. Choity , Wasiu G. Balogun , Ruyu Shi , Margaret A. Bedison , Brian J. Lopresti , Cristy Matan , Neelesh K. Nadkarni , Alexandra Gogola , Elizabeth C. Shaaban , Howard J. Aizenstein , Dana L. Tudorascu , Tharick A. Pascoal , Victor L. Villemagne , Sarah B. Berman , Milos D. Ikonomovic , Robert A. Sweet , Julia K. Kofler , Beth E. Snitz , Ilyas M. Kamboh , Ann D. Cohen , Oscar L. Lopez , Thomas K Karikari medRxiv 2026.10.19.26365317; doi: https://doi.org/10.64898/2026.10.19.26365317 Share This Article: Copy Citation Tools Plasma biomarkers and incident clinical stage progression in the specialized memory clinic: a longitudinal study Xuemei zeng , Nicholas Heaton , Rebecca A. Deek , Michel N. Nafash , Marissa F. Farinas , Lamia T. Choity , Wasiu G. Balogun , Ruyu Shi , Margaret A. Bedison , Brian J. Lopresti , Cristy Matan , Neelesh K. Nadkarni , Alexandra Gogola , Elizabeth C. Shaaban , Howard J. Aizenstein , Dana L. Tudorascu , Tharick A. Pascoal , Victor L. Villemagne , Sarah B. Berman , Milos D. Ikonomovic , Robert A. Sweet , Julia K. Kofler , Beth E. Snitz , Ilyas M. Kamboh , Ann D. Cohen , Oscar L. Lopez , Thomas K Karikari medRxiv 2026.10.19.26365317; doi: https://doi.org/10.64898/2026.10.19.26365317 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Areas All Articles Addiction Medicine (631) Allergy and Immunology (914) Anesthesia (343) Cardiovascular Medicine (4936) Dentistry and Oral Medicine (490) Dermatology (425) Emergency Medicine (668) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1664) Epidemiology (16148) Forensic Medicine (35) Gastroenterology (1232) Genetic and Genomic Medicine (7198) Geriatric Medicine (747) Health Economics (1087) Health Informatics (5212) Health Policy (1454) Health Systems and Quality Improvement (1811) Hematology (597) HIV/AIDS (1369) Infectious Diseases (except HIV/AIDS) (16416) Intensive Care and Critical Care Medicine (1191) Medical Education (689) Medical Ethics (156) Nephrology (738) Neurology (7479) Nursing (374) Nutrition (1112) Obstetrics and Gynecology (1275) Occupational and Environmental Health (1028) Oncology (3704) Ophthalmology (1078) Orthopedics (401) Otolaryngology (462) Pain Medicine (489) Palliative Medicine (142) Pathology (715) Pediatrics (1841) Pharmacology and Therapeutics (747) Primary Care Research (780) Psychiatry and Clinical Psychology (6059) Public and Global Health (9903) Radiology and Imaging (2495) Rehabilitation Medicine and Physical Therapy (1497) Respiratory Medicine (1262) Rheumatology (655) Sexual and Reproductive Health (793) Sports Medicine (593) Surgery (794) Toxicology (109) Transplantation (315) Urology (302)
## Related Clinical Research

- [Ultra-processed foods linked to MRI signs of vascular brain injury in middle-aged adults](https://medichelpline.com/clinical-feed/medical-news-today-0-ultra-processed-foods-may-be-harming-brain-health-in-otherwise-healthy-adults.md)
- [Global dementia incidence projected to reach 24.7 million new cases annually by 2050](https://medichelpline.com/clinical-feed/medical-news-today-0-dementia-cases-to-double-by-2050-why-women-some-countries-may-be-at-higher-risk.md)
- [Context-dependent variability of NOTCH3 p.Arg1231Cys: from asymptomatic carriers to CADASIL and li](https://medichelpline.com/clinical-feed/medrxiv-9-from-asymptomatic-carriers-to-cadasil-context-dependent-phenotypic-variability.md)
- [Explainable multimodal speech framework for detecting depression-related signals in Alzheimer's di](https://medichelpline.com/clinical-feed/medrxiv-0-an-explainable-multimodal-framework-for-exploring-depression-associated-speech.md)
- [Pre-diagnostic 1-year prevalence of polypharmacy and PIMcog in Norwegian outpatients with MCI or d](https://medichelpline.com/clinical-feed/plos-one-14-one-year-pre-diagnostic-prevalence-and-associated-factors-of-polypharmacy-and.md)

## Navigation
- [← Back to Neurology Feed](https://medichelpline.com/clinical-feed/neurology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.